BioSpace News Archive

IVERIC bio today announced that due to the threat of the coronavirus (COVID-19) global pandemic, the Company has decided to delay the initiation of enrollment of patients in the second pivotal clinical trial for Zim

IMV Inc. announced that it has entered into an equity distribution agreement, dated March 18, 2020, with Piper Sandler & Co. as agent, pursuant to which the Company may, from time to time sell, through “at-the-market” offerings with Piper Sandler acting as sales agent, on the Nasdaq Capital Market such number of common shares as would have an aggregate offering price of up to US$30 million under the ATM Prospectus Supplement.

Inspirational Stories from Patients, Survivors, and Supporters Raise Awareness About the Broad Impact of Prostate Cancer on Millions Across the U.S.

Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that Sandra Suarez-Sharp, Ph.D., has joined the company as Vice President, Regulatory Affairs to oversee the new Regulatory Strategies team supporting companies in their interactions with global health authorities.

Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today the selection of VT-105, a universal influenza vaccine candidate for clinical development. Versatope uses recombinant outer membrane vesicles (rOMVs) that are based on research from Cornell University Professors David Putnam

AXIM ® Biotechnologies, Inc. announced today that the Company has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). In January of this year, AXIM announced that the Company signed a binding term sheet to acquire Sapphire.

Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB: KLFE), a biopharmaceutical med-chem company specializing in the research and development of potent novel monotherapeutics, announced today that the Company has been issued Australian Patent AU2015204609B2 (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy.” This patent grant marks the seventh paten

In light of continuing operational impacts of the Coronavirus Disease / COVID-19 pandemic, Allegiant Travel Company (NASDAQ: ALGT) today announced a slate of strategic measures aimed at strengthening the company’s balance sheet, consolidating demand while continuing to provide service to customers, protecting health and safety, and enabling a solid foundation for the future.

StartX , a non-profit startup community of more than 1500 Stanford faculty and alumni founders, announces the launch of its StartX Med COVID-19 Task Force and the mobilization of its breakthrough medical companies providing so

The Deputy Prime Minister will join ministers and Government of Canada officials to provide an update on coronavirus disease (COVID-19).